FDA / CDER: Programa 2018 de Visita ao Centro de Aprendizagem Experiencial de Qualidade Farmacêutica (OPQ)
SUMMARY: The Center for Drug Evaluation and Research (CDER) in the Food and Drug Administration (FDA) is announcing the 2018 CDER Office of Pharmaceutical Quality (OPQ) Staff Experiential Learning Site Visit Program. The purpose of this document is to invite pharmaceutical companies interested in participating in this program to submit a site visit proposal to CDER’s OPQ.
DATES: Submit either an electronic or written proposal to participate in this program by February 2, 2018. See section IV of this document for information on what to include in such proposals.
For more go to information https://www.gpo.gov/fdsys/pkg/FR-2017-12-04/pdf/2017-26055.pdf